
No name. No product. No confirmed funding. And, possibly, a $2bn price tag. That is the shape of the newest bet in AI drug discovery. Miles Wang, a researcher at OpenAI, is leaving to start his own company, TechCrunch reported. He is in talks to raise …

Chai Discovery’s $400m raise triples its value to $3.8bn in seven months. It is the latest sign that AI drug discovery has moved from promise to deployment. AI drug discovery just minted another fast-rising star. Chai Discovery has raised a $400m Serie…

Zipline said the number of businesses offering delivery through its app grew 13 times during the first half of 2026. The autonomous drone delivery company has now completed more than 2.5 million commercial deliveries, including one million in the last …

The pitch for medical AI is that it frees clinicians to care for patients. Two stories this week suggest the reality can run the other way. In New York, nurses say software replaced them. In Minnesota, a former Mayo Clinic leader says the software was …

In the space of about ten days, US lawmakers introduced a small mountain of artificial-intelligence legislation. The bills, rounded up by Nextgov/FCW, pull in two opposite directions at once. One set treats AI as a tool the government should be deployi…

The convergence of advanced skincare science and consumer electronics is rewriting the rules of personal care. For decades, individuals relied entirely on the passive application of topical formulas, smoothing a cream over the skin surface and hoping t…

Two robots that look roughly like people just reached inside a live animal and removed an organ. No film studio staged the scene. It happened in a lab in California, and it is a first for medicine. Surgeons at the University of California San Diego use…

Auxilium Biotechnologies has bioprinted kidney and liver tissue aboard the International Space Station. It says that is the first time anyone has made either in space. The samples flew home last month on a SpaceX cargo capsule, and the company announce…